Following a TRAIL: update on a ligand and its five receptors - sprookjes - yvandenbroek - TriplyDB

Following a TRAIL: update on a ligand and its five receptors

Following a TRAIL: update on a ligand and its five receptors

http://www.wikidata.org/entity/Q28292767

about

TRAIL/DR5 signaling promotes macrophage foam cell formation by modulating scavenger receptor expression Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants.Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients.The TRAIL to viral pathogenesis: the good, the bad and the ugly The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases Targeting AML through DR4 with a novel variant of rhTRAIL The plasticity of regulatory T cell function DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.Following the TRAIL from hepatitis C virus and alcohol to fatty liver Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines.Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene Polymorphisms and Hepatitis B Virus Infection Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion.Transformation, translation and TRAIL: an unexpected intersection.TRAIL, caspases and maturation of normal and leukemic myeloid precursors.Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium.Abnormal Expression of TRAIL Receptors in Decidual Tissue of Chlamydia trachomatis-Infected Rats During Early Pregnancy Loss.Use of allogeneic NK cells for cancer immunotherapy.Finding the place of histone deacetylase inhibitors in prostate cancer therapy.TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.Resistance to TRAIL and how to surmount it.Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways.Stage-dependent effects of exogenous TRAIL on atherogenesis: role of ER stress-mediated sensitization of macrophage apoptosis.Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.Rotundarpene prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and Bid-pathways and the mitochondrial pathway.Combination treatment for glioblastoma cells with tumor necrosis factor-related apoptosis-inducing ligand and oncolytic adenovirus delta-24.Experiment research on inhibition of glioma with sTRAIL in vitro.Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1.Stellera chamaejasme L. extract induces apoptosis of human lung cancer cells via activation of the death receptor-dependent pathway.Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra.Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.Increased p53 level, Bax/Bcl-x(L) ratio, and TRAIL receptor expression in human emphysema.DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis.

P2860

Q27325727-B5F315E3-146A-45EB-BE0C-CA4991E12DD2 Q28394059-77B4C0D3-4F29-4381-9E59-6C375CB6D303 Q28565846-E5C47022-B2F1-47C5-B36A-B0A425F9B3E9 Q33523025-C60A4105-3DB6-44CC-8FF9-47F5DDD96B26 Q34561798-5D188E46-D6D6-4869-A192-CC40FCAAEF60 Q34695283-D8BE8DD6-E015-41F0-80C2-6C6499CC55CA Q34712125-11A1E310-DACA-4C1A-A5C2-588D411F578A Q35146349-EFF6857A-A2EE-428E-B711-7FFAA2AF090E Q35172090-9DA963F9-2AFC-4C12-AF04-EAAEB7E20D85 Q35377418-6ECE189D-2BA3-4DAF-8D71-7C573EA85FD7 Q35523783-E07625C7-8EB0-4FE9-8190-59EC1F91A6B8 Q35536334-AC254D9B-8E26-4222-9A00-C3C552E76BD0 Q35897444-10467DAD-6BD3-48EC-A2DE-A200C1CBCAFA Q36215003-218AE748-E481-4566-8E38-1FE28F42E401 Q36287589-2794EDA3-5EAE-486B-8F19-3E25B6B0CC28 Q36338510-55AEAC33-6A88-4B18-BCD3-4B8F268F4539 Q36528568-E5F65018-EF38-4082-89A7-B6A808102F29 Q36547702-08586E68-B399-4794-AF90-539AB0954E1D Q36571532-CF645197-6768-423A-B673-874DF61D2B81 Q36590964-F22E198C-1EA4-49DA-B68B-DF4F83EEDE56 Q37207081-E951BBC9-488F-49FB-B714-A2876F88B540 Q37835361-7EDAAED4-D8C4-490E-BDEA-7DE1959E0D87 Q37957140-B8A63FA0-34D5-4D8C-99EF-90A94E107A2A Q37960198-A67E0C54-01DA-4B9C-9FD1-BA24FA46261C Q37972139-010CD313-B788-4CB6-B58F-5E071EA2657B Q37992546-979E54F7-7BD7-4BBA-B4FB-C70BFB9B2B73 Q38090691-7C638328-346C-4DFD-B5C8-5466392FF5CD Q38790660-10026F16-585C-4AB7-9733-0030A6061B53 Q38792057-F70B71E4-6F3D-454C-87AC-9D2843BA920D Q38914267-33F6215C-B04C-49F0-8B54-BB80E9765083 Q38951550-1ED1FB70-D5DE-480E-B6E7-18C853A50441 Q39069742-594F9B5D-5186-456A-A1D9-D6080D2082A2 Q39071318-641E95F7-0077-43EE-8973-E34A6AC840F5 Q39214017-547DDF3C-5EF0-487C-A4D6-2EA4CE5B34CE Q39241292-545A44A4-4F7B-4224-93A7-6D7BD19D8CBE Q39305649-97871FA2-A18B-4A40-93C8-46A859897BFF Q39875342-A6D73B28-2D71-4247-9CCF-3AA859C82F1C Q39977214-4A48E5D5-608E-46BF-BE5A-9CF60BF4C6AF Q39982958-30EED0AB-793C-4F0A-A9BD-DF1695DA5F87 Q40038240-BFD8EC97-F874-4869-BED9-4F142C547744

P2860

Following a TRAIL: update on a ligand and its five receptors

http://www.wikidata.org/entity/Q28292767

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Following a TRAIL: update on a ligand and its five receptors

@ast

Following a TRAIL: update on a ligand and its five receptors

@en

Following a TRAIL: update on a ligand and its five receptors

@nl

type

label

Following a TRAIL: update on a ligand and its five receptors

@ast

Following a TRAIL: update on a ligand and its five receptors

@en

Following a TRAIL: update on a ligand and its five receptors

@nl

prefLabel

Following a TRAIL: update on a ligand and its five receptors

@ast

Following a TRAIL: update on a ligand and its five receptors

@en

Following a TRAIL: update on a ligand and its five receptors

@nl

P1433

Q28292767-C2FAF6C2-7200-4DFE-87A7-D2907166F8BF

P1476

Q28292767-EAAACB0C-0311-41DD-B70E-7A7616CC042A

P2093

Q28292767-0C09C4F9-8878-44B2-A609-82C766ED65D0

P2860

Q28292767-0072DCF0-98BB-4723-A1FA-E9336625E86A

Q28292767-00FE80B0-C78D-4A4A-A546-83FD4A92F94C

Q28292767-0117C2CD-A2AC-44CA-8D58-4BA4E3231425

Q28292767-06757D88-BFA6-4413-86D1-C3E5E119501B

Q28292767-09C7B597-02FE-4695-9714-E6FFB462C383

Q28292767-0F489E7B-0D7D-44A3-9CA5-B52E18C792B7

Q28292767-1440CBC7-A656-41DD-9BED-A3D1950F9129

Q28292767-19624AF1-DC95-42E9-A508-AE81CF92076E

Q28292767-1A0C4183-2C57-4F64-A5B4-3FFAC1DAA2F6

Q28292767-1C03C7C9-C24E-4DA7-AECE-E635FD9672C5

P2888

Q28292767-BBC7BD55-0994-4709-8ED7-88848626ACED

P304

Q28292767-B61CEC63-A63C-4078-A37F-683CAD9F4B93

P31

Q28292767-4995C711-CEBF-4EBF-BC8B-9137A8EC7467

P3181

Q28292767-20DD7D5F-C979-447B-93CB-0E86D6325D38

P356

Q28292767-20049993-DB08-4DA7-B551-2279127FF165

P407

Q28292767-582CB17C-2CB3-4A96-8B83-9E2F403200B3

P433

Q28292767-AA50D260-0E32-4633-9355-ACD2B0E0479C

P478

Q28292767-BC6073B8-A395-41F4-A1FE-0C50A0E7733E

P50

Q28292767-362F2A9C-5521-4BD4-993F-F2FE1795C474

P577

Q28292767-D6FAE9F9-5FA8-477E-A887-8078D710297B

P5875

Q28292767-6FCDA47B-69AE-4FF3-AD7D-5DCB54680317

P698

Q28292767-367F0AFB-A05B-4752-AF5F-FDF14D23CC0B

P3181

P356

P1433

P1476

Following a TRAIL: update on a ligand and its five receptors

@en

P2093

Fiona C Kimberley

http://www.w3.org/2001/XMLSchema#string

P2860

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations

Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

The receptor for the cytotoxic ligand TRAIL

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

Identification and characterization of a new member of the TNF family that induces apoptosis

P2888

P304

359-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4005973

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.CR.7290236

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Gavin R Screaton

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51369966

http://www.w3.org/2001/XMLSchema#string

P698

15538968

http://www.w3.org/2001/XMLSchema#string